Literature DB >> 29387196

Decreased microRNA-181a and -16 expression levels in the labial salivary glands of Sjögren syndrome patients.

Yuhua Wang1, Guohua Zhang1, Lingling Zhang1, Miansong Zhao1, Hongdong Huang1.   

Abstract

Sjögren syndrome (SS) is characterized by dysfunction of the exocrine glands, particularly the salivary and lacrimal glands. Thus, labial salivary gland biopsy is useful method for diagnosing SS. The aim of the present study was to investigate the microRNA (miRNA or miR) profile of labial salivary glands obtained from SS patients and to examine the correlation of miR-181a and -16 levels with the pathological grade in SS. miRNA expression in labial salivary gland tissues was profiled in 3 female patients with primary SS and 3 female patients with non-SS sicca syndrome using microarray analysis. In addition, a literature search and miRNA target gene prediction were performed to collect miRNAs involved in SS pathogenesis. Subsequent to integrating all database results, miR-181a and -16 were identified to be associated with the Ro/SS-associated antigen A and La/SS-associated antigen B during SS pathogenesis. Therefore, these miRNAs were selected for further verification in labial salivary gland tissues of 28 patients with SS and 18 non-SS sicca syndrome control individuals by quantitative reverse transcription-quantitative polymerase chain reaction. Compared with the control group, 76 miRNAs were upregulated and 51 were downregulated in the labial salivary gland of SS patients according to microarray results. In particular, miR-181a and -16 expression levels in the labial salivary gland of SS patients were decreased in comparison with those in the controls. Furthermore, the decreased expression levels of these miRNAs were associated with the labial salivary pathological focus scores. In conclusion, the present study examined the miRNA profiles in the labial salivary glands of SS patients and detected decreased miR-181a and -16 expression levels compared with the control individuals. Finally, the decreased levels of miR-181a and -16 were associated with the salivary gland pathological focus scores, suggesting that miR-181a and -16 may serve a role in the pathogenesis of SS.

Entities:  

Keywords:  Sjögren syndrome; labial salivary gland; microRNA-16; microRNA-181a

Year:  2017        PMID: 29387196      PMCID: PMC5769212          DOI: 10.3892/etm.2017.5407

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  34 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 3.  The role of microRNAs in the pathogenesis of autoimmune diseases.

Authors:  Ji-Qing Chen; Gábor Papp; Péter Szodoray; Margit Zeher
Journal:  Autoimmun Rev       Date:  2016-09-15       Impact factor: 9.754

4.  Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants.

Authors:  Troy E Daniels; Darren Cox; Caroline H Shiboski; Morten Schiødt; Ava Wu; Hector Lanfranchi; Hisanori Umehara; Yan Zhao; Stephen Challacombe; Mi Y Lam; Yvonne De Souza; Julie Schiødt; Helena Holm; Patricia A M Bisio; Mariana S Gandolfo; Toshioki Sawaki; Mengtao Li; Wen Zhang; Beni Varghese-Jacob; Per Ibsen; Alicia Keszler; Nozomu Kurose; Takayuki Nojima; Edward Odell; Lindsey A Criswell; Richard Jordan; John S Greenspan
Journal:  Arthritis Rheum       Date:  2011-07

5.  Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity.

Authors:  Kaleb M Pauley; Carol M Stewart; Adrienne E Gauna; Lauren C Dupre; Riya Kuklani; Annie L Chan; Brad A Pauley; Westley H Reeves; Edward K L Chan; Seunghee Cha
Journal:  Eur J Immunol       Date:  2011-05-27       Impact factor: 5.532

6.  miR-146a and miR-155 expression in PBMCs from patients with Sjögren's syndrome.

Authors:  Huan Shi; Ling-yan Zheng; Ping Zhang; Chuang-qi Yu
Journal:  J Oral Pathol Med       Date:  2014-06-14       Impact factor: 4.253

7.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

8.  Circulating microRNA expression profiles associated with systemic lupus erythematosus.

Authors:  Anting Liu Carlsen; Aaron J Schetter; Christoffer T Nielsen; Christian Lood; Steen Knudsen; Anne Voss; Curtis C Harris; Thomas Hellmark; Mårten Segelmark; Søren Jacobsen; Anders A Bengtsson; Niels H H Heegaard
Journal:  Arthritis Rheum       Date:  2013-05

9.  Lung tumorigenesis induced by human vascular endothelial growth factor (hVEGF)-A165 overexpression in transgenic mice and amelioration of tumor formation by miR-16.

Authors:  Yu-Tang Tung; Pin-Wu Huang; Yu-Ching Chou; Cheng-Wei Lai; Hsiu-Po Wang; Heng-Chien Ho; Chih-Ching Yen; Chih-Yen Tu; Tung-Chou Tsai; Dah-Cherng Yeh; Jiun-Long Wang; Kowit-Yu Chong; Chuan-Mu Chen
Journal:  Oncotarget       Date:  2015-04-30

Review 10.  MicroRNA: important player in the pathobiology of multiple myeloma.

Authors:  Chonglei Bi; Wee Joo Chng
Journal:  Biomed Res Int       Date:  2014-06-03       Impact factor: 3.411

View more
  9 in total

1.  Genetics and epigenetics in primary Sjögren's syndrome.

Authors:  Juliana Imgenberg-Kreuz; Astrid Rasmussen; Kathy Sivils; Gunnel Nordmark
Journal:  Rheumatology (Oxford)       Date:  2021-05-14       Impact factor: 7.580

Review 2.  MicroRNA in Sjögren's Syndrome: Their Potential Roles in Pathogenesis and Diagnosis.

Authors:  M Reale; C D'Angelo; E Costantini; M Laus; A Moretti; A Croce
Journal:  J Immunol Res       Date:  2018-06-07       Impact factor: 4.818

Review 3.  Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren's Syndrome through an Impaired Epigenetic Control: The State-of-The-Art.

Authors:  Rossella Talotta; Piercarlo Sarzi-Puttini; Fabiola Atzeni
Journal:  J Immunol Res       Date:  2019-01-06       Impact factor: 4.818

4.  Advances in Pathogenesis of Sjögren's Syndrome.

Authors:  Yao Tian; Hongyi Yang; Na Liu; Yan Li; Jie Chen
Journal:  J Immunol Res       Date:  2021-10-07       Impact factor: 4.818

Review 5.  Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren's Syndrome and Primary Biliary Cholangitis.

Authors:  Pinelopi Arvaniti; Kalliopi Zachou; Aggeliki Lyberopoulou; Nikolaos K Gatselis; Wesley H Brooks; George N Dalekos; Yves Renaudineau
Journal:  Epigenomes       Date:  2019-08-08

6.  Tear miRNAs Identified in a Murine Model of Sjögren's Syndrome as Potential Diagnostic Biomarkers and Indicators of Disease Mechanism.

Authors:  Shruti Singh Kakan; Maria C Edman; Alexander Yao; Curtis T Okamoto; Annie Nguyen; Brooke E Hjelm; Sarah F Hamm-Alvarez
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

7.  Small RNA Expression Profiling Reveals hsa-miR-181d-5p Downregulation Associated With TNF-α Overexpression in Sjögren's Syndrome Patients.

Authors:  Isabel Castro; Patricia Carvajal; Daniela Jara; Sergio Aguilera; Benjamín Heathcote; María-José Barrera; Víctor Aliaga-Tobar; Vinicius Maracaja-Coutinho; Ulises Urzúa; Andrew F G Quest; Sergio González; Claudio Molina; Marcela Hermoso; María-Julieta González
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

Review 8.  Update on Sjögren's Syndrome 2018.

Authors:  Ourania D Argyropoulou; Athanasios G Tzioufas
Journal:  Mediterr J Rheumatol       Date:  2018-12-18

Review 9.  Epigenetic Regulation in the Pathogenesis of Sjögren Syndrome and Rheumatoid Arthritis.

Authors:  José Santiago Ibáñez-Cabellos; Marta Seco-Cervera; Rebeca Osca-Verdegal; Federico V Pallardó; José Luis García-Giménez
Journal:  Front Genet       Date:  2019-11-13       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.